Central to NETLAS (tuneable lasers for OCT), HandheldOCT (handheld imaging devices), and MOON (multi-modal optical diagnostics).
INNOLUME GMBH
German SME manufacturing quantum dot semiconductor lasers for optical coherence tomography and high-speed datacom applications.
Their core work
Innolume is a German SME specializing in semiconductor laser technology, particularly quantum dot lasers and tuneable laser sources for optical coherence tomography (OCT) and datacom applications. They develop advanced laser components used in medical imaging devices — enabling high-resolution, non-invasive diagnostics for ocular and neurodegenerative diseases. Their work also extends into silicon photonics integration and photonic assembly for high-speed optical transceivers, bridging the gap between semiconductor research and commercial photonic products.
What they specialise in
Caladan focuses on GaAs quantum dot lasers for datacom, and NETLAS on semiconductor laser development for medical imaging.
Caladan project addresses micro transfer printing and photonic assembly for terabit-capable optical transceivers.
HandheldOCT targets portable diagnostic devices; MOON addresses ocular and neurodegenerative disease diagnostics.
INDEED project on innovative nanowire device design, likely contributing laser or semiconductor expertise.
How they've shifted over time
Innolume's early H2020 involvement (2016-2017) focused on broader photonics research — optical diagnostics for disease and nanowire device design — without strong keyword specificity, suggesting a component-supplier role in exploratory consortia. From 2019 onward, their focus sharpened dramatically toward applied laser technology: silicon photonics for datacom (Caladan), tuneable lasers for OCT (NETLAS), and handheld diagnostic devices (HandheldOCT). The trajectory shows a clear move from general semiconductor R&D toward application-specific laser products in medical imaging and optical communications.
Innolume is converging on tuneable laser sources for portable medical imaging — expect future work in miniaturized OCT systems and point-of-care photonic devices.
How they like to work
Innolume operates exclusively as a participant, never as coordinator — typical for a specialized SME that contributes deep technical components rather than managing consortia. With 48 unique partners across 15 countries in just 5 projects, they work in large, diverse consortia (averaging ~10 partners per project). This pattern suggests they are sought after as a reliable laser technology provider that integrates well into multi-partner research teams.
Innolume has built a broad European network of 48 partners across 15 countries through 5 projects — an unusually wide reach for a small company, indicating strong reputation in the photonics community. Their partnerships span universities, research institutes, and industrial players across the photonics and medical device sectors.
What sets them apart
Innolume occupies a rare niche: a commercially-oriented SME that manufactures quantum dot semiconductor lasers — a technology few European companies can deliver. Their dual capability in both telecom/datacom lasers and medical OCT laser sources makes them a versatile photonics partner. For consortium builders, they offer real hardware and manufacturing know-how, not just research — a critical gap-filler in projects that need to demonstrate working prototypes.
Highlights from their portfolio
- HandheldOCTLargest single funding (EUR 933,750) — developing portable OCT devices for point-of-care diagnostics, representing Innolume's highest-value and most application-ready project.
- CaladanBridges photonics and datacom — terabit-capable optical transceivers using GaAs quantum dot lasers and micro transfer printing, showing Innolume's reach beyond medical into telecommunications.
- NETLASDirectly targets next-generation tuneable lasers for OCT — the project most aligned with Innolume's core product line and future direction.